POSEIDA THERAPEUTICS INC revenue breakdown overview

POSEIDA THERAPEUTICS INC revenue for the last year amounted to 58.62 M EUR, the most of which — 58.62 M EUR — came from its highest performing source at the moment, Cell and Gene Therapies, the year earlier bringing 121.93 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought POSEIDA THERAPEUTICS INC 58.62 M EUR, and the year before that — 121.93 M EUR.